Patents by Inventor Douglas L. Rector
Douglas L. Rector has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 5049561Abstract: This invention concerns a process for killing internal parasites, especially nematodes, trematodes and cestodes affecting warm blooded animals such as sheep, cattle, swine, goats, dogs, cats, horses and humans as well as poultry by administering an effective amount of a compound of the Formula I. ##STR1## The compounds are readily prepared by conventional chemical reactions.Type: GrantFiled: January 30, 1990Date of Patent: September 17, 1991Assignee: The Upjohn CompanyInventors: Douglas L. Rector, George A. Conder, Sylvester D. Folz
-
Patent number: 5023334Abstract: This invention concerns a process for killing internal parasites, especially nematodes and cestodes affecting warm blooded animals such as sheep, cattle, swine, goats, dogs, cats, horses and humans as well as poultry by administering an effective amount of a compound of the Formula I: ##STR1## Certain of the compounds of Formula I are novel and in further embodiments of the invention provide novel compounds and compositions for use in the process of the invention. The compounds are readily prepared by conventional chemical reactions. Various pyridinyl acylhydrazones of Formula I demonstrate broad-spectrum anthelmintic activity in sheep upon oral and/or parenteral administration.Type: GrantFiled: September 1, 1989Date of Patent: June 11, 1991Assignee: The Upjohn CompanyInventors: Douglas L. Rector, George A. Conder, Sylvester D. Folz
-
Patent number: 5011932Abstract: This invention concerns a process for killing internal parasites, especially nematodes and cestodes affecting warm blooded animals such as sheep, cattle, swine, goats, dogs, cats, horses and humans as well as poultry by administering an effective amount of a compound of the Formula I: ##STR1## Certain of the compounds of Formula I are novel and in further embodiments of the invention provide novel compounds and compositions for use in the process of the invention. The compounds are readily prepared by conventional chemical reactions. Various pyridinyl acylhydrazones of Formula I demonstrate broad-spectrum anthelmintic activity in sheep upon oral and/or parenteral administration.Type: GrantFiled: October 3, 1986Date of Patent: April 30, 1991Assignee: Upjohn CompanyInventors: Douglas L. Rector, George A. Conder, Sylvester D. Folz
-
Patent number: 4978670Abstract: This invention concerns a process for killing internal parasites, especially nematodes, trematodes and cestodes affecting warm blooded animals such as sheep, cattle, swine, goats, dogs, cats, horses and humans as well as poultry by administering an effective amount of a compound of the Formula I. ##STR1## The compounds are readily prepared by conventional chemical reactions.Type: GrantFiled: October 7, 1988Date of Patent: December 18, 1990Assignee: The Upjohn CompanyInventors: Douglas L. Rector, George A. Conder, Sylvester D. Folz
-
Patent number: 4870082Abstract: This invention concerns a process for killing internal parasites, especially nematodes and cestodes affecting warm blooded animals such as sheep, cattle, swine, goats, dogs, cats, horses and humans as well as poultry by administering an effective amount of a compound of the Formula I: ##STR1## Certain of the compounds of Formula I are novel and in further embodiments of the invention provide novel compounds and compositions for use in the process of the invention. The compounds are readily prepared by conventional chemical reactions.Type: GrantFiled: November 24, 1986Date of Patent: September 26, 1989Assignee: The Upjohn CompanyInventors: Douglas L. Rector, George A. Conder, Sylvester D. Folz
-
Patent number: 4112100Abstract: A method of improving the endogenous production of prostaglandins by a mammal is disclosed which comprises administering to the mammal an effective amount of certain 1-pyridylalkyl-3-phenylthioureas. Disclosed also are novel substituted 1-pyridylalkyl-3-phenylthioureas and therapeutic compositions thereof which are useful in carrying out the method of the invention.Disclosed also are methods of treating mammals for clinical conditions responsive to prostaglandins, such as for example, male infertility, epidermal injuries, atonic uterine bleeding, thromboembolic disease and like clinical conditions.Type: GrantFiled: June 25, 1975Date of Patent: September 5, 1978Assignee: The Upjohn CompanyInventors: William A. Callahan, Eldridge Myles Glenn, Douglas L. Rector
-
Patent number: 4088766Abstract: A method of improving the endogenous production of prostaglandins by a mammal is disclosed, which comprises administering to the mammal an effective amount of certain 1-pyridylalkyl-3-phenylureas. Disclosed also are novel substituted 1-pyridylalkyl-3-phenylureas and therapeutic compositions thereof which are useful in carrying out the method of the invention.Disclosed also are methods of treating mammals for clinical conditions responsive to prostaglandins, such as, for example, male infertility, epidermal injuries, atonic uterine bleeding, thromboembolic disease and like clinical conditions.Type: GrantFiled: December 2, 1976Date of Patent: May 9, 1978Assignee: The Upjohn CompanyInventors: William A. Callahan, Eldridge M. Glenn, Douglas L. Rector
-
Patent number: 4069224Abstract: A method of improving the endogenous production of prostaglandins by a mammal is disclosed, which comprises administering to the mammal an effective amount of an N-(pyridylalkyl)benzamides. Disclosed also are novel N-(pyridylalkyl)benzamides and therapeutic compositions thereof which are useful in carrying out the method of the invention.Disclosed also are methods of treating mammals for clinical conditions responsive to prostaglandins, such as for example, male infertility, epidermal injuries, atonic uterine bleeding, thromboembolic disease and like clinical conditions.Type: GrantFiled: June 25, 1975Date of Patent: January 17, 1978Assignee: The Upjohn CompanyInventors: William A. Callahan, Eldridge Myles Glenn, Douglas L. Rector
-
Patent number: 4008326Abstract: A method of improving the endogenous production of prostaglandins by a mammal is disclosed, which comprises administering to the mammal an effective amount of 1-pyridylalkyl-3-naphthyl-2(thio)ureas. Disclosed also are novel substituted 1-pyridylalkyl-3-naphthyl-2(thio)ureas and therapeutic compositions thereof which are useful in carrying out the method of the invention.Disclosed also are methods of treating mammals for clinical conditions responsive to prostaglandins, such as, for example, male infertility, epidermal injuries, atonic uterine bleeding, thromboembolic disease and like clinical conditions.Type: GrantFiled: June 25, 1975Date of Patent: February 15, 1977Assignee: The Upjohn CompanyInventors: William A. Callahan, Eldridge Myles Glenn, Douglas L. Rector
-
Patent number: 4001256Abstract: A method of improving the endogenous production of prostaglandins by a mammal is disclosed, which comprises administering to the mammal an effective amount of certain 1-pyridylalkyl-3-phenylureas. Disclosed also are novel substituted 1-pyridylalkyl-3-phenylureas and therapeutic compositions thereof which are useful in carrying out the method of the invention.Disclosed also are methods of treating mammals for clinical conditions responsive to prostaglandins, such as, for example, male infertility, epidermal injuries, atonic uterine bleeding, thromboembolic disease and like clinical conditions.Type: GrantFiled: June 25, 1975Date of Patent: January 4, 1977Assignee: The Upjohn CompanyInventors: William A. Callahan, Eldridge Myles Glenn, Douglas L. Rector